WALTHAM, Mass. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB held in Rome, Italy September 4-7 .

Philadelphia, Pennsylvania May 23-27, 2012

Will Demonstrate NC-stat® DPNCheck™ and Provide First Look at SENSUS™ Pain Management Device

Quell ™ Wearable Pain Relief and DPNCheck ® Neuropathy Test to be Featured WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians better manage chronic

Will Feature SENSUS Pain Management System and DPNCheck Peripheral Neuropathy Test WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic

Will Feature the SENSUS Pain Management System

Malvern (U.K.) Diabetic Foot Conference on May 14-16, 2014 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases,

NeuroMetrix To Exhibit at Medtrade Tradeshow and Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today

Will Support a Hands-On Workshop on Evaluation of Diabetic Peripheral Neuropathy

Preview for New Product Targeted at Diabetes Market